Precision Medicine
PreceDo’s precision medicine ecosystem is anchored by its nationally licensed living primary cell biobank (Human Genetic Resource Preservation License, Approval No. [2022] BC0101) and its independently operated medical laboratory. We deliver end‑to‑end precision medicine solutions for hospitals, research institutions, and regional health authorities, including organoid biobank development, personalized drug sensitivity testing, cell banking, and digital twin informatics platforms. Our mission is to accelerate the clinical adoption of personalized medicine and improve patient outcomes worldwide.
PreceDo’s precision medicine ecosystem is anchored by its nationally licensed living primary cell biobank (Human Genetic Resource Preservation License, Approval No. [2022] BC0101) and its independently operated medical laboratory. We deliver end‑to‑end precision medicine solutions for hospitals, research institutions, and regional health authorities, including organoid biobank development, personalized drug sensitivity testing, cell banking, and digital twin informatics platforms. Our mission is to accelerate the clinical adoption of personalized medicine and improve patient outcomes worldwide.
Reprogramming Cells, Empowering Medicine
©2026 PreceDo Biotechnology Co., Ltd. Powered by：www.300.cn